{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T15:37:09Z","timestamp":1774366629450,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82100557"],"award-info":[{"award-number":["82100557"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32030048"],"award-info":[{"award-number":["32030048"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271256"],"award-info":[{"award-number":["82271256"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    There is compelling evidence that TNF preferentially activates and expands CD4\n                    <jats:sup>+<\/jats:sup>\n                    Foxp3\n                    <jats:sup>+<\/jats:sup>\n                    regulatory T cells (Tregs) through TNFR2. However, the precise mechanisms underlying TNF-TNFR2 pathway-mediated Treg proliferation remain to be fully elucidated. In this study, using RNA-seq profiling of TNFR2\n                    <jats:sup>+<\/jats:sup>\n                    and TNFR2-deficient Treg cells, we identified that\n                    <jats:italic>Trip13<\/jats:italic>\n                    is required for promoting TNF-TNFR2 pathway-mediated Treg expansion. Mechanistically, TRIP13 inhibited UBE4A-mediated ubiquitination degradation of HAT1 by directly binding to HAT1, thereby competing with UBE4A and promoting Treg expansion. In addition, TRIP13\u2019s ATPase activity was essential for its binding to HAT1, which promoted Treg expansion by increasing Foxp3 expression. In a mouse colitis model, TRIP13 overexpression markedly alleviated colon inflammation by enhancing Treg expansion, an effect that was reversed by HAT1 knockdown. Conversely, genetic ablation of TRIP13 substantially reversed the effects induced by HAT1 overexpression, including enhanced Treg expansion and attenuation of colitis. These findings illustrate the TRIP13\/HAT1 axis-mediated mechanism for TNF-TNFR2-induced Treg expansion and indicate that targeting TRIP13 may offer therapeutic potential for autoimmune and inflammatory diseases.\n                  <\/jats:p>","DOI":"10.1038\/s41419-025-08214-7","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T15:26:48Z","timestamp":1768404408000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["TRIP13 promotes the expansion and immunosuppression of CD4+Foxp3+ regulatory T cells by sustaining HAT1 stability"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7873-853X","authenticated-orcid":false,"given":"Tianzhen","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liwen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chu-Ting","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-Ya","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shengnan","family":"Jing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5073-4200","authenticated-orcid":false,"given":"Ke","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3040-1545","authenticated-orcid":false,"given":"Siyu","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yingchun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhuting","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chon-Kit","family":"Chou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2628-4027","authenticated-orcid":false,"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7432-7458","authenticated-orcid":false,"given":"Yong-Jing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"8214_CR1","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","volume":"133","author":"S Sakaguchi","year":"2008","unstructured":"Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T cells and immune tolerance. Cell. 2008;133:775\u201387.","journal-title":"Cell"},{"key":"8214_CR2","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nri1806","volume":"6","author":"W Zou","year":"2006","unstructured":"Zou W. Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol. 2006;6:295\u2013307.","journal-title":"Nat Rev Immunol"},{"key":"8214_CR3","first-page":"654","volume":"6","author":"AL Perdigoto","year":"2015","unstructured":"Perdigoto AL, Chatenoud L, Bluestone JA, Herold KC. Inducing and administering tregs to treat human disease. Front Immunol. 2015;6:654.","journal-title":"Front Immunol"},{"key":"8214_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176862","volume":"979","author":"J Ji","year":"2024","unstructured":"Ji J, Liang Q, He Q, Chen T, Feng G, Guo H, et al. Overexpression of miR-20a-5p in mesenchymal stem cell derived-exosomes from systemic lupus erythematosus patients restored therapeutic effect and Treg immune regulation. Eur J Pharm. 2024;979:176862.","journal-title":"Eur J Pharm"},{"key":"8214_CR5","doi-asserted-by":"publisher","first-page":"154","DOI":"10.4049\/jimmunol.179.1.154","volume":"179","author":"X Chen","year":"2007","unstructured":"Chen X, B\u00e4umel M, M\u00e4nnel DN, Howard OM, Oppenheim JJ. Interaction of TNF with TNF receptor type 2 promotes expansion and function of mouse CD4+CD25+ T regulatory cells. J Immunol. 2007;179:154\u201361.","journal-title":"J Immunol"},{"key":"8214_CR6","doi-asserted-by":"publisher","first-page":"6467","DOI":"10.4049\/jimmunol.180.10.6467","volume":"180","author":"X Chen","year":"2008","unstructured":"Chen X, Subleski JJ, Kopf H, Howard OM, Mannel DN, Oppenheim JJ. Cutting edge: expression of TNFR2 defines a maximally suppressive subset of mouse CD4+CD25+FoxP3+ T regulatory cells: applicability to tumor-infiltrating T regulatory cells. J Immunol. 2008;180:6467\u201371.","journal-title":"J Immunol"},{"key":"8214_CR7","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1002\/eji.200940022","volume":"40","author":"X Chen","year":"2010","unstructured":"Chen X, Subleski JJ, Hamano R, Howard OM, Wiltrout RH, Oppenheim JJ. Co-expression of TNFR2 and CD25 identifies more of the functional CD4+FOXP3+ regulatory T cells in human peripheral blood. Eur J Immunol. 2010;40:1099\u2013106.","journal-title":"Eur J Immunol"},{"key":"8214_CR8","doi-asserted-by":"publisher","first-page":"174","DOI":"10.4049\/jimmunol.0903548","volume":"185","author":"X Chen","year":"2010","unstructured":"Chen X, Hamano R, Subleski JJ, Hurwitz AA, Howard OM, Oppenheim JJ. Expression of costimulatory TNFR2 induces resistance of CD4+FoxP3- conventional T cells to suppression by CD4+FoxP3+ regulatory T cells. J Immunol. 2010;185:174\u201382.","journal-title":"J Immunol"},{"key":"8214_CR9","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.4049\/jimmunol.1202659","volume":"190","author":"X Chen","year":"2013","unstructured":"Chen X, Wu X, Zhou Q, Howard OM, Netea MG, Oppenheim JJ. TNFR2 is critical for the stabilization of the CD4+Foxp3+ regulatory T. cell phenotype in the inflammatory environment. J Immunol. 2013;190:1076\u201384.","journal-title":"J Immunol"},{"key":"8214_CR10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.cyto.2013.09.008","volume":"65","author":"Q Zhou","year":"2014","unstructured":"Zhou Q, Hu Y, Howard OM, Oppenheim JJ, Chen X. In vitro generated Th17 cells support the expansion and phenotypic stability of CD4+Foxp3+ regulatory T cells in vivo. Cytokine. 2014;65:56\u201364.","journal-title":"Cytokine"},{"key":"8214_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.108823","volume":"108","author":"T He","year":"2022","unstructured":"He T, Zhao Y, Zhao P, Zhao L, Zakaria J, Wang K. Signaling pathway(s) of TNFR2 required for the immunoregulatory effect of CD4+Foxp3+ regulatory T cells. Int Immunopharmacol. 2022;108:108823.","journal-title":"Int Immunopharmacol"},{"key":"8214_CR12","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1084\/jem.20151255","volume":"213","author":"DX Nguyen","year":"2016","unstructured":"Nguyen DX, Ehrenstein MR. Anti-TNF drives regulatory T cell expansion by paradoxically promoting membrane TNF-TNF-RII binding in rheumatoid arthritis. J Exp Med. 2016;213:1241\u201353.","journal-title":"J Exp Med"},{"key":"8214_CR13","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1084\/jem.20151563","volume":"213","author":"M Chopra","year":"2016","unstructured":"Chopra M, Biehl M, Steinfatt T, Brandl A, Kums J, Amich J, et al. Exogenous TNFR2 activation protects from acute GvHD via host T reg cell expansion. J Exp Med. 2016;213:1881\u20131900.","journal-title":"J Exp Med"},{"key":"8214_CR14","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1182\/blood-2016-02-700849","volume":"128","author":"M Leclerc","year":"2016","unstructured":"Leclerc M, Naserian S, Pilon C, Thiolat A, Martin GH, Pouchy C, et al. Control of GVHD by regulatory T cells depends on TNF produced by T cells and TNFR2 expressed by regulatory T cells. Blood. 2016;128:1651\u20139.","journal-title":"Blood"},{"key":"8214_CR15","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1182\/blood-2016-04-711275","volume":"128","author":"A Pierini","year":"2016","unstructured":"Pierini A, Strober W, Moffett C, Baker J, Nishikii H, Alvarez M, et al. TNF-alpha priming enhances CD4+FoxP3+ regulatory T-cell suppressive function in murine GVHD prevention and treatment. Blood. 2016;128:866\u201371.","journal-title":"Blood"},{"key":"8214_CR16","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.07367","volume":"4","author":"Q Ye","year":"2015","unstructured":"Ye Q, Rosenberg SC, Moeller A, Speir JA, Su TY, Corbett KD. TRIP13 is a protein-remodeling AAA+ ATPase that catalyzes MAD2 conformation switching. Elife. 2015;4:e07367.","journal-title":"Elife"},{"key":"8214_CR17","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.1002\/1878-0261.12821","volume":"14","author":"S Agarwal","year":"2020","unstructured":"Agarwal S, Behring M, Kim HG, Chandrashekar DS, Chakravarthi B, Gupta N, et al. TRIP13 promotes metastasis of colorectal cancer regardless of p53 and microsatellite instability status. Mol Oncol. 2020;14:3007\u201329.","journal-title":"Mol Oncol"},{"key":"8214_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202104291","volume":"9","author":"M Rios Garcia","year":"2022","unstructured":"Rios Garcia M, Meissburger B, Chan J, de Guia RM, Mattijssen F, Roessler S, et al. Trip13 depletion in liver cancer induces a lipogenic response contributing to plin2-dependent mitotic cell death. Adv Sci. 2022;9:2104291.","journal-title":"Adv Sci"},{"key":"8214_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.693477","volume":"8","author":"L Zeng","year":"2021","unstructured":"Zeng L, Liu YM, Yang N, Zhang T, Xie H. Hsa_circRNA_100146 promotes prostate cancer progression by upregulating TRIP13 via sponging miR-615-5p. Front Mol Biosci. 2021;8:693477.","journal-title":"Front Mol Biosci"},{"key":"8214_CR20","first-page":"86","volume":"36","author":"A Mohammed","year":"2025","unstructured":"Mohammed A, Ali ME-H, Mohamed FEA, Abd-Elrehim DM. Immunohistochemical expression of TRIP13 in transitional and squamous cell carcinoma of urinary bladder carcinoma. Minia J Med Res. 2025;36:86\u201396.","journal-title":"Minia J Med Res"},{"key":"8214_CR21","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1002\/1878-0261.13201","volume":"16","author":"S Agarwal","year":"2022","unstructured":"Agarwal S, Afaq F, Bajpai P, Kim HG, Elkholy A, Behring M, et al. DCZ0415, a small-molecule inhibitor targeting TRIP13, inhibits EMT and metastasis via inactivation of the FGFR4\/STAT3 axis and the Wnt\/\u03b2-catenin pathway in colorectal cancer. Mol Oncol. 2022;16:1728\u201345.","journal-title":"Mol Oncol"},{"key":"8214_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/cai2.147","volume":"3","author":"S Jing","year":"2024","unstructured":"Jing S, Zhao L, Zhao L, Gao YJ, He T. TRIP13: a promising cancer immunotherapy target. Cancer Innov. 2024;3:e147.","journal-title":"Cancer Innov"},{"key":"8214_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2023.100951","volume":"47","author":"F Afaq","year":"2023","unstructured":"Afaq F, Agarwal S, Bajpai P, Diffalha SA, Kim HG, Peter S, et al. Targeting of oncogenic AAA-ATPase TRIP13 reduces progression of pancreatic ductal adenocarcinoma. Neoplasia. 2023;47:100951.","journal-title":"Neoplasia"},{"key":"8214_CR24","doi-asserted-by":"publisher","first-page":"e1003518","DOI":"10.1371\/journal.pgen.1003518","volume":"9","author":"P Nagarajan","year":"2013","unstructured":"Nagarajan P, Ge Z, Sirbu B, Doughty C, Agudelo Garcia PA, Schlederer M, et al. Histone acetyl transferase 1 is essential for mammalian development, genome stability, and the processing of newly synthesized histones H3 and H4. PLoS Genet. 2013;9:e1003518.","journal-title":"PLoS Genet"},{"key":"8214_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.740588","volume":"13","author":"T Sarkar","year":"2022","unstructured":"Sarkar T, Dhar S, Chakraborty D, Pati S, Bose S, Panda AK, et al. FOXP3\/HAT1 axis controls Treg infiltration in the tumor microenvironment by inducing CCR4 expression in breast cancer. Front Immunol. 2022;13:740588.","journal-title":"Front Immunol"},{"key":"8214_CR26","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.molcel.2019.11.003","volume":"77","author":"Y Yuan","year":"2020","unstructured":"Yuan Y, Miao Y, Qian L, Zhang Y, Liu C, Liu J, et al. Targeting UBE4A revives viperin protein in epithelium to enhance host antiviral defense. Mol Cell. 2020;77:734\u2013747.e7.","journal-title":"Mol Cell"},{"key":"8214_CR27","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1002\/eji.200324506","volume":"34","author":"X Chen","year":"2004","unstructured":"Chen X, Murakami T, Oppenheim JJ, Zack Howard OM. Differential response of murine CD4+CD25+ and CD4+CD25- T cells to dexamethasone-induced cell death. Eur J Immunol. 2004;34:859\u201369.","journal-title":"Eur J Immunol"},{"key":"8214_CR28","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/embor.2008.93","volume":"9","author":"F Ikeda","year":"2008","unstructured":"Ikeda F, Dikic I. Atypical ubiquitin chains: new molecular signals. 'Protein modifications: beyond the usual suspects' review series. EMBO Rep. 2008;9:536\u201342.","journal-title":"EMBO Rep"},{"key":"8214_CR29","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41586-018-0281-1","volume":"559","author":"C Alfieri","year":"2018","unstructured":"Alfieri C, Chang L, Barford D. Mechanism for remodelling of the cell cycle checkpoint protein MAD2 by the ATPase TRIP13. Nature. 2018;559:274\u20138.","journal-title":"Nature"},{"key":"8214_CR30","doi-asserted-by":"publisher","first-page":"13961","DOI":"10.1073\/pnas.1207912109","volume":"109","author":"J Symersky","year":"2012","unstructured":"Symersky J, Osowski D, Walters DE, Mueller DM. Oligomycin frames a common drug-binding site in the ATP synthase. Proc Natl Acad Sci USA. 2012;109:13961\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"8214_CR31","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s13402-022-00742-0","volume":"46","author":"T He","year":"2023","unstructured":"He T, Chen Y, Yang D, Islam MS, Chou CK, Liu J, et al. TNFR2 antagonistic antibody induces the death of tumor infiltrating CD4+Foxp3+ regulatory T cells. Cell Oncol. 2023;46:167\u201377.","journal-title":"Cell Oncol"},{"key":"8214_CR32","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aba6584","volume":"6","author":"T He","year":"2020","unstructured":"He T, Yang D, Li XQ, Jiang M, Islam MS, Chen S, et al. Inhibition of two-pore channels in antigen-presenting cells promotes the expansion of TNFR2-expressing CD4+Foxp3+ regulatory T cells. Sci Adv. 2020;6:eaba6584.","journal-title":"Sci Adv"},{"key":"8214_CR33","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1158\/0008-5472.CAN-18-3987","volume":"80","author":"Y Wang","year":"2020","unstructured":"Wang Y, Huang J, Li B, Xue H, Tricot G, Hu L, et al. A small-molecule inhibitor targeting TRIP13 suppresses multiple myeloma progression. Cancer Res. 2020;80:536\u201348.","journal-title":"Cancer Res"},{"key":"8214_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-018-0704-y","volume":"18","author":"J Yao","year":"2018","unstructured":"Yao J, Zhang X, Li J, Zhao D, Gao B, Zhou H, et al. Silencing TRIP13 inhibits cell growth and metastasis of hepatocellular carcinoma by activating of TGF-\u03b21\/smad3. Cancer Cell Int. 2018;18:208.","journal-title":"Cancer Cell Int"},{"key":"8214_CR35","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abi4613","volume":"7","author":"JM Moreau","year":"2022","unstructured":"Moreau JM, Velegraki M, Bolyard C, Rosenblum MD, Li Z. Transforming growth factor-\u03b21 in regulatory T cell biology. Sci Immunol. 2022;7:eabi4613.","journal-title":"Sci Immunol"},{"key":"8214_CR36","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1038\/s41401-024-01299-4","volume":"45","author":"CY Hou","year":"2024","unstructured":"Hou CY, Lv P, Yuan HF, Zhao LN, Wang YF, Zhang HH, et al. Bevacizumab induces ferroptosis and enhances CD8+ T cell immune activity in liver cancer via modulating HAT1 and increasing IL-9. Acta Pharm Sin. 2024;45:1951\u201363.","journal-title":"Acta Pharm Sin"},{"key":"8214_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/jbt.23039","volume":"36","author":"FY Lin","year":"2022","unstructured":"Lin FY, Han ST, Yu WM, Rao T, Ruan Y, Yuan R, et al. microRNA-486-5p is implicated in the cisplatin-induced apoptosis and acute inflammation response of renal tubular epithelial cells by targeting HAT1. J Biochem Mol Toxicol. 2022;36:e23039.","journal-title":"J Biochem Mol Toxicol"},{"key":"8214_CR38","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13046-019-1044-z","volume":"38","author":"P Fan","year":"2019","unstructured":"Fan P, Zhao J, Meng Z, Wu H, Wang B, Wu H, et al. Overexpressed histone acetyltransferase 1 regulates cancer immunity by increasing programmed death-ligand 1 expression in pancreatic cancer. J Exp Clin Cancer Res. 2019;38:47.","journal-title":"J Exp Clin Cancer Res"},{"key":"8214_CR39","doi-asserted-by":"publisher","first-page":"2991","DOI":"10.2147\/COPD.S280614","volume":"15","author":"J Zhang","year":"2020","unstructured":"Zhang J, Xu Z, Kong L, Gao H, Zhang Y, Zheng Y, et al. miRNA-486-5p promotes COPD progression by targeting HAT1 to regulate the TLR4-triggered inflammatory response of alveolar macrophages. Int J Chron Obstruct Pulmon Dis. 2020;15:2991\u20133001.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"8214_CR40","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/3201062","volume":"2019","author":"ML Vlad","year":"2019","unstructured":"Vlad ML, Manea SA, Lazar AG, Raicu M, Muresian H, Simionescu M, et al. Histone acetyltransferase-dependent pathways mediate upregulation of NADPH oxidase 5 in human macrophages under inflammatory conditions: a potential mechanism of reactive oxygen species overproduction in atherosclerosis. Oxid Med Cell Longev. 2019;2019:3201062.","journal-title":"Oxid Med Cell Longev"},{"key":"8214_CR41","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.bbrc.2015.11.128","volume":"472","author":"D Liu","year":"2016","unstructured":"Liu D, Zhang M, Xie W, Lan G, Cheng HP, Gong D, et al. MiR-486 regulates cholesterol efflux by targeting HAT1. Biochem Biophys Res Commun. 2016;472:418\u201324.","journal-title":"Biochem Biophys Res Commun"},{"key":"8214_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagrm.2022.194900","volume":"1866","author":"N Kumar","year":"2023","unstructured":"Kumar N, Mondal M, Arathi BP, Sundaresan NR, Somasundaram K. Histone acetyltransferase 1 (HAT1) acetylates hypoxia-inducible factor 2 alpha (HIF2A) to execute hypoxia response. Biochim Biophys Acta BBA Gene Regul Mech. 2023;1866:194900.","journal-title":"Biochim Biophys Acta BBA Gene Regul Mech"},{"key":"8214_CR43","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/s41419-021-04118-4","volume":"12","author":"Y Sun","year":"2021","unstructured":"Sun Y, Ren D, Zhou Y, Shen J, Wu H, Jin X. Histone acetyltransferase 1 promotes gemcitabine resistance by regulating the PVT1\/EZH2 complex in pancreatic cancer. Cell Death Dis. 2021;12:878.","journal-title":"Cell Death Dis"},{"key":"8214_CR44","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41419-022-04564-8","volume":"13","author":"C Xie","year":"2022","unstructured":"Xie C, Long F, Li L, Li X, Ma M, Lu Z, et al. PTBP3 modulates P53 expression and promotes colorectal cancer cell proliferation by maintaining UBE4A mRNA stability. Cell Death Dis. 2022;13:128.","journal-title":"Cell Death Dis"},{"key":"8214_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14274","volume":"8","author":"C Liu","year":"2017","unstructured":"Liu C, Liu W, Ye Y, Li W. Ufd2p synthesizes branched ubiquitin chains to promote the degradation of substrates modified with atypical chains. Nat Commun. 2017;8:14274.","journal-title":"Nat Commun"},{"key":"8214_CR46","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/nsb906","volume":"10","author":"MD Ohi","year":"2003","unstructured":"Ohi MD, Vander Kooi CW, Rosenberg JA, Chazin WJ, Gould KL. Structural insights into the U-box, a domain associated with multi-ubiquitination. Nat Struct Biol. 2003;10:250\u20135.","journal-title":"Nat Struct Biol"},{"key":"8214_CR47","doi-asserted-by":"publisher","first-page":"7797","DOI":"10.3390\/ijms24097797","volume":"24","author":"T Fiyouzi","year":"2023","unstructured":"Fiyouzi T, Pelaez-Prestel HF, Reyes-Manzanas R, Lafuente EM, Reche PA. Enhancing regulatory T cells to treat inflammatory and autoimmune diseases. Int J Mol Sci. 2023;24:7797.","journal-title":"Int J Mol Sci"},{"key":"8214_CR48","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41419-018-1266-6","volume":"10","author":"S Yang","year":"2019","unstructured":"Yang S, Xie C, Chen Y, Wang J, Chen X, Lu Z, et al. Differential roles of TNF\u03b1-TNFR1 and TNF\u03b1-TNFR2 in the differentiation and function of CD4+Foxp3+ induced Treg cells in vitro and in vivo periphery in autoimmune diseases. Cell Death Dis. 2019;10:27.","journal-title":"Cell Death Dis"},{"key":"8214_CR49","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.intimp.2019.01.040","volume":"69","author":"H Zou","year":"2019","unstructured":"Zou H, He T, Chen X. Tetrandrine inhibits differentiation of proinflammatory subsets of T helper cells but spares de novo differentiation of iTreg cells. Int Immunopharmacol. 2019;69:307\u201312.","journal-title":"Int Immunopharmacol"},{"key":"8214_CR50","volume":"9","author":"M Mensink","year":"2024","unstructured":"Mensink M, Verleng LJ, Schrama E, Janssen GM, Tjokrodirijo RT, van Veelen PA, et al. Tregs from human blood differentiate into nonlymphoid tissue-resident effector cells upon TNFR2 costimulation. JCI Insight. 2024;9:e172942.","journal-title":"JCI Insight"},{"key":"8214_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9419","volume":"6","author":"D Hu","year":"2015","unstructured":"Hu D, Gur M, Zhou Z, Gamper A, Hung MC, Fujita N, et al. Interplay between arginine methylation and ubiquitylation regulates KLF4-mediated genome stability and carcinogenesis. Nat Commun. 2015;6:8419.","journal-title":"Nat Commun"},{"key":"8214_CR52","first-page":"4557","volume":"7","author":"U Erben","year":"2014","unstructured":"Erben U, Loddenkemper C, Doerfel K, Spieckermann S, Haller D, Heimesaat MM, et al. A guide to histomorphological evaluation of intestinal inflammation in mouse models. Int J Clin Exp Pathol. 2014;7:4557\u201376.","journal-title":"Int J Clin Exp Pathol"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08214-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08214-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08214-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T17:02:27Z","timestamp":1768410147000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-08214-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8214"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-08214-7","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"assertion":[{"value":"4 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"32"}}